Application restriction endonucleases Bst2U I and Acc65 I to find Kpn I - Polymorphism in NAT2 gene

Biomeditsinskaya Khimiya

Volumn 50, Issue 3, 2004, Pages 269-272

  Nikishina, M V ^a   Akishev, A G ^a   Makarova, S I ^a   Vavilin, V A ^a   Degtyarev, S Kh ^a   Lyakhovich, V V ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Genetic polymorphism; N acetyltransferase; Point mutations; Restriction endonucleases; RFLP analysis

Indexed keywords

ENDONUCLEASE; GENE PRODUCT; ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN; RESTRICTION ENDONUCLEASE;

ARTICLE; DNA DETERMINATION; DNA POLYMORPHISM; ENZYME ASSAY; GENETIC ANALYSIS; HUMAN; POINT MUTATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS;

ARYLAMINE N-ACETYLTRANSFERASE; DNA RESTRICTION ENZYMES; HUMANS; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 6344248909     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hein D. V., Grant D.M., Sim E. (2000) Pharmacogenetics, 10, 291-292.
2. Woolhouse N.M., Quershi MM., Bastaki S.M.A., Patel M., Abdulrazzad Y., Bayoumi R.A.I. (1997) Pharmacogenetics, 7, 73-82.
3. Hickman D., Palamanda J.R., Unadkat J.D., Sim E. (1995) Biochem. Pharmacol., 50, 697-703.
4. Leff M.A., Fretland A.J., Doll M.A., Hein D.W. (1999) J. Biol. Chem., 274, 34519-34522.
5. Bandmann O., Vaughan J.R., Holmans P., Marsden C.D., Wood N.W. (2000) Mov. Disord., 15, 30-35.
6. Hein D. W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Devanaboyin U.S., Nangju N.A., Fend Y. (2000) Cancer Epidemiol. Biomarkers Prev., 9, 29-42.
7. Lee E.J., Zhao B., Seow-Choen F. (1998) Pharmacogenetics., 8, 513-517.
8. Kunkel L.M., Smith K.D., Boyer S.H., Bordgaonkar D.S., Wachtel S.S., Miller O.J., Bred W.R., Jones H.W., Rary J.M. (1977) Proc. Natl. Acad. Sci. USA, 74, 1245-1249.
9. Hickman D., Sim E. (1991) Biochem. Pharmacol., 42, 1007-1014.
10. Shishikura K., Hohjoh H., Tokunaga K. (2000) Hum. Mutat., 15, 581.